2026-04-17T10:39:27Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/78022024-12-13T10:44:07Zcom_2072_378070com_2072_378040col_2072_378092

Future care for long-term cancer survivors: towards a new model Romero Rodriguez, Nieves Tabernero Caturla, Josep Vera, Ruth Baz, David Vicente Arraiza-Armendariz, Antonio Provencio, Mariano Institut Català de la Salut [Provencio M] Medical Oncology Department, Spanish Lung Cancer Group (GECP), Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. [Romero N] Cardiology and Cardiac Surgery Clinical Management Unit, Hospital Virgen del Rocio, Sevilla, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. European Society for Medical Oncology (ESMO), Barcelona, Spain. [Vera R] Medical Oncology Department, Complejo Hospitalario de Navarra, Servicio Navarro de la Salud, Spanish Society of Medical Oncology (SEOM), Navarra, Spain. [Baz DV] Medical Oncology Department, Hospital Universitario Virgen Macarena, Andalusian Comprehensive Oncology Plan, Sevilla, Spain. [Arraiza A] Health Programmes, Health Care, Osakidetza, País Vasco, Spain Vall d'Hebron Barcelona Hospital Campus Càncer - Tractament Medicina - Presa de decisions DISEASES::Neoplasms Other subheadings::Other subheadings::Other subheadings::/therapy ENFERMEDADES::neoplasias Otros calificadores::Otros calificadores::Otros calificadores::/terapia Long cancer survivor; Multidisciplinary cancer care Sobreviviente de cáncer; Atención multidisciplinar del cáncer Supervivent del càncer; Atenció multidisciplinària del càncer Purpose The increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to increase the cost of LCS care. The aim of this study was to obtain information that would allow to optimise the current model of health management in Spain to adapt it to one of efficient LCS patient care. Methods This qualitative study was carried out using Delphi methodology. An advisory committee defined the criteria for participation, select the panel of experts, prepare the questionnaire, interpret the results and draft the final report. Results 232 people took part in the study (48 oncologists). Absolute consensus was reached in three of the proposed sections: oncological epidemiology, training of health professionals and ICT functions. Conclusion The role of primary care in the clinical management of LCS patients needs to be upgraded, coordination with the oncologist and hospital care is essential. The funding model needs to be adapted to determine the funding conditions for new drugs and technologies. Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This project was funded by AZ. The funding party did not influence the opinion of the authors. All the authors have accepted the participation as advisers of the ASISTO group and give their consent for the publication of the document. 2022-07-19T07:41:35Z 2022-07-19T07:41:35Z 2022-02 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Provencio M, Romero N, Tabernero J, Vera R, Baz DV, Arraiza A, et al. Future care for long-term cancer survivors: towards a new model. Clin Transl Oncol. 2022 Feb;24:350–62. 1699-3055 https://hdl.handle.net/11351/7802 10.1007/s12094-021-02696-5 34716541 000712723700001 http://hdl.handle.net/11351/7802 eng Clinical and Translational Oncology;24 https://doi.org/10.1007/s12094-021-02696-5 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess application/pdf Springer Scientia